Skin ulcer preventive curative agent containing human recombinant hgf

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060199762A1
SERIAL NO

10570046

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A neovascularization promoting composition, a granulation formation-promoting composition and a preventive or curative composition for skin ulcer, comprising a human recombinant HGF wherein five amino acid residues are deleted in the first Kringle domain thereof. The provided compositions of the present invention are useful as a drug capable of promoting granulation formation and neovascularization and being effective in tissue restoration, especially as a preventive and curative agent for skin ulcer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KRINGLE PHARMA INCOSAKA 567-0085
TOSHIKAZU NAKAMURA1-4 HOSHOJICHO OKAZAKI SAKYO-KU KYOTO-SHI KYOTO 606-8333

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Itami, Satoshi Hyogo, JP 16 583
Matsumoto, Kunio Osaka, JP 62 1185
Nakamura, Toshikazu Kyoto, JP 159 1525
Yoshida, Saho Osaka, JP 2 2
Yoshikawa, Kunihiko Osaka, JP 13 211

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation